Refine Results
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
To be enabled for e-commerce, you must first register. Agilent will then confirm your registration and inform you when your enablement is complete and you can begin transacting.
E-commerce is currently not available in your country. For select consumables and supplies you may now use Saved Cart link under your Account to build lists and send to your Agilent Representative. Simply login or register and you may begin.
The development and manufacturing of biosimilars require comparability studies with innovator biotherapeutic products.
- Publication Part Number: 5994-1495EN
- Created: 15 Oct 2024
- 2 MB
| Korean (Korea) | Complete (PDF) |
|---|---|
| Chinese (Simplified) (China) | Complete (PDF) |
A Comparative Study of the Intact Mass, Subunit Mass, and Released Glycans of Two Rituximab Biosimilars Using High-Resolution LC/MS
- Publication Part Number: 5994-1653EN
- Created: 15 Oct 2024
- 1 MB
| Chinese (Simplified) (China) | Complete (PDF) |
|---|---|
| Korean (Korea) | Complete (PDF) |
LC/MS based characterization workflow of the GLP-1 therapeutic peptide liraglutide and its impurities using the 1290 Infinity II LC and 6545XT AdvanceBio LC/Q-TOF.
- Publication Part Number: 5994-7727EN
- Created: 25 Sep 2024
- 3 MB
The development and manufacturing of biosimilars require comparability studies with innovator biotherapeutic products.
- Publication Part Number: 5994-1496EN
- Created: 25 Oct 2019
- 2 MB
| Korean (Korea) | Complete (PDF) |
|---|---|
| Chinese (Simplified) (China) | Complete (PDF) |
Demonstration of robust and reliable peptide mapping and characterization of post-translational modifications in mAbs using an AdvanceBio Peptide Plus...
- Publication Part Number: 5991-8046JAJP
- Created: 09 Mar 2018
- 1 MB
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
本應(yīng)用摘要針對(duì)序列圖譜分析提供了一套完整的高通量工作流程解決方案。
- Publication Part Number: 5991-7815CHCN
- Created: 24 Mar 2017
- 2 MB
| Japanese (Japan) | Complete (PDF) |
|---|